Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyan Xu

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Neuroendocrinology|March 12, 2024
Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1Junyan Xu, Xiaoping Xu, Meng Zhang, et al.
Se Pu = Chinese Journal of Chromatography|January 26, 2022
[Analysis of glycan ratio of Chinese hamster ovary cell-cetuximab antigen-binding segment via rapid enzyme digestion with endo-<i>β</i>-<i>N</i>-acetylglucosaminidase F]Qian Cheng, Daihui Jia, Bohui Zhang, et al.
Radiology. Imaging Cancer|October 18, 2024
Assessing the Value of <sup>68</sup>Ga-FAPI PET/CT in Gastric Mucinous Adenocarcinoma or Signet Ring Cell CarcinomaYuyun Sun, Junyan Xu, Ying Qiao, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 31, 2017
Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal AdenocarcinomaQingguo Li, Yaqi Li, Junyan Xu, et al.
Endocrine-Related Cancer|January 16, 2026
Systemic Therapy for Advanced Pheochromocytoma and Paraganglioma: Real-World Evidence from a Single Center CohortYun Liang, Junyan Xu, Dan Huang, et al.
The Oncologist|May 27, 2025
Efficacy and safety of surufatinib in the treatment of thymic neuroendocrine tumors: a 102-case retrospective studyXuebing Jia, Zhichen Sun, Junyan Xu, et al.
Lab on a Chip|April 24, 2023
Enrichment and detection of VEGF<sub>165</sub> in blood samples on a microfluidic chip integrated with multifunctional unitsXinyu He, Junyan Xu, Xiaoli Wang, et al.
The Analyst|May 22, 2015
Evaluation of separation properties of a modified strong cation exchange material named MEX and its application in 2D-MEX × C18 system to separate peptides from scorpion venomBo Chen, Junyan Xu, Qing Fu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 29, 2012
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancerZhongyi Yang, Lingling Pan, Jingyi Cheng, et al.
Nuclear Medicine Communications|March 14, 2018
Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patientsShuai Liu, Xingzhu Ju, Zheng Feng, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Neuroendocrinology|March 12, 2024
Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1Junyan Xu, Xiaoping Xu, Meng Zhang, et al.
Se Pu = Chinese Journal of Chromatography|January 26, 2022
[Analysis of glycan ratio of Chinese hamster ovary cell-cetuximab antigen-binding segment via rapid enzyme digestion with endo-<i>β</i>-<i>N</i>-acetylglucosaminidase F]Qian Cheng, Daihui Jia, Bohui Zhang, et al.
Radiology. Imaging Cancer|October 18, 2024
Assessing the Value of <sup>68</sup>Ga-FAPI PET/CT in Gastric Mucinous Adenocarcinoma or Signet Ring Cell CarcinomaYuyun Sun, Junyan Xu, Ying Qiao, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 31, 2017
Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal AdenocarcinomaQingguo Li, Yaqi Li, Junyan Xu, et al.
Endocrine-Related Cancer|January 16, 2026
Systemic Therapy for Advanced Pheochromocytoma and Paraganglioma: Real-World Evidence from a Single Center CohortYun Liang, Junyan Xu, Dan Huang, et al.
The Oncologist|May 27, 2025
Efficacy and safety of surufatinib in the treatment of thymic neuroendocrine tumors: a 102-case retrospective studyXuebing Jia, Zhichen Sun, Junyan Xu, et al.
Lab on a Chip|April 24, 2023
Enrichment and detection of VEGF<sub>165</sub> in blood samples on a microfluidic chip integrated with multifunctional unitsXinyu He, Junyan Xu, Xiaoli Wang, et al.
The Analyst|May 22, 2015
Evaluation of separation properties of a modified strong cation exchange material named MEX and its application in 2D-MEX × C18 system to separate peptides from scorpion venomBo Chen, Junyan Xu, Qing Fu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 29, 2012
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancerZhongyi Yang, Lingling Pan, Jingyi Cheng, et al.
Nuclear Medicine Communications|March 14, 2018
Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patientsShuai Liu, Xingzhu Ju, Zheng Feng, et al.
Pageof 8